1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Cotoretigene Toliparvovec: new trials by email Literature Review of Cotoretigene Toliparvovec trials Research Report on Cotoretigene Toliparvovec
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis Pigmentosa BIIB111, BIIB112 - Choroideremia, X-Linked Retinitis Pigmentosa | Phase 3 | Completed | NightstaRx Ltd, a Biogen Company | 277 | 2018-06-04 | 2026-07-06 |
Choroideremia (1)
NightstaRx Ltd, a Biogen Company (1)
Brazil (1) · Canada (1) · Denmark (1) · Finland (1) · France (1) · Germany (1) · Netherlands (1) · United Kingdom (1) · United States (1)
2017 (1)